Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (571-580 of 706) with videos related to

Pageof 71
Sort By:
Journal of Paediatrics and Child Health|August 13, 2021
Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in AustraliaAndrew C Martin, Amanda J Hooper, Richard Norman, et al.
Atherosclerosis|April 26, 2026
Long-term trends in dyslipidemia prevalence, awareness, treatment, and control in the Middle East and North Africa: a meta-analysis of 116 representative surveysEhsaneh Taheri, Shirin Esmaeili, Saeed Hamidizadeh, et al.
European Journal of Preventive Cardiology|March 30, 2018
Health literacy in familial hypercholesterolemia: A cross-national studyMartin S Hagger, Sarah J Hardcastle, Miao Hu, et al.
European Heart Journal|January 13, 2021
Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemiaLeopoldo Pérez de Isla, Gerald F Watts, Rodrigo Alonso, et al.
Journal of Clinical Lipidology|May 13, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Journal of the American Heart Association|February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID StudyMalcolm West, Adrienne Kirby, Ralph A Stewart, et al.
Atherosclerosis|October 2, 2018
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemiaMartin S Hagger, Sarah J Hardcastle, Miao Hu, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 7, 2021
The effect of Vitamin-K<sub>1</sub> and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trialJamie W Bellinge, Roslyn J Francis, Sing Ching Lee, et al.
Atherosclerosis|April 16, 2026
Liver transplantation in severe homozygous familial hypercholesterolaemia: a scoping reviewJing Pang, Samuel S Gidding, Erin Kelty, et al.
The New England Journal of Medicine|May 29, 2024
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed HyperlipidemiaRobert S Rosenson, Daniel Gaudet, Robert A Hegele, et al.
Pageof 71

Showing results (571-580 of 706) with videos related to

Sort By:
Pageof 71
Journal of Paediatrics and Child Health|August 13, 2021
Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in AustraliaAndrew C Martin, Amanda J Hooper, Richard Norman, et al.
Atherosclerosis|April 26, 2026
Long-term trends in dyslipidemia prevalence, awareness, treatment, and control in the Middle East and North Africa: a meta-analysis of 116 representative surveysEhsaneh Taheri, Shirin Esmaeili, Saeed Hamidizadeh, et al.
European Journal of Preventive Cardiology|March 30, 2018
Health literacy in familial hypercholesterolemia: A cross-national studyMartin S Hagger, Sarah J Hardcastle, Miao Hu, et al.
European Heart Journal|January 13, 2021
Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemiaLeopoldo Pérez de Isla, Gerald F Watts, Rodrigo Alonso, et al.
Journal of Clinical Lipidology|May 13, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Journal of the American Heart Association|February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID StudyMalcolm West, Adrienne Kirby, Ralph A Stewart, et al.
Atherosclerosis|October 2, 2018
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemiaMartin S Hagger, Sarah J Hardcastle, Miao Hu, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 7, 2021
The effect of Vitamin-K<sub>1</sub> and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trialJamie W Bellinge, Roslyn J Francis, Sing Ching Lee, et al.
Atherosclerosis|April 16, 2026
Liver transplantation in severe homozygous familial hypercholesterolaemia: a scoping reviewJing Pang, Samuel S Gidding, Erin Kelty, et al.
The New England Journal of Medicine|May 29, 2024
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed HyperlipidemiaRobert S Rosenson, Daniel Gaudet, Robert A Hegele, et al.
Pageof 71